Preoperative and postoperative management of the bariatric surgical patient

Journal of Clinical Outcomes Management

Volumn 14, Issue 5, 2007, Pages 262-274

  Pietras, Sara M ^a   Usdan, Lisa S ^a   Apovian, Caroline M ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CYANOCOBALAMIN; DIURETIC AGENT; ENOXAPARIN; FERROUS SULFATE; FOLIC ACID; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IRON; METFORMIN; MULTIVITAMIN; SELENIUM; SULFONYLUREA; THIAMINE; VITAMIN D; ZINC;

BARIATRIC SURGERY; BILIOPANCREATIC DIVISION; BLEEDING; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLECYSTECTOMY; CIGARETTE SMOKING; CLINICAL PRACTICE; COMORBIDITY; CONVALESCENCE; CUSHING SYNDROME; CYANOCOBALAMIN DEFICIENCY; DEEP VEIN THROMBOSIS; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DUODENUM; EXERCISE; GALLSTONE; GASTRIC BANDING; HAIR LOSS; HEALTH CARE FACILITY; HEPATOBILIARY SYSTEM; HORMONAL THERAPY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCISIONAL HERNIA; LABORATORY TEST; LAPAROSCOPIC SURGERY; LOW DRUG DOSE; MALABSORPTION; MENTAL DISEASE; NEPHROLITHIASIS; NEUROLOGICAL COMPLICATION; NONALCOHOLIC FATTY LIVER; NUTRITIONAL DEFICIENCY; NUTRITIONAL SUPPORT; OBESITY; PANCREAS; PARTIAL GASTRECTOMY; PATIENT CARE; PATIENT SELECTION; PEPTIC ULCER; PERSONALITY DISORDER; POSITIVE END EXPIRATORY PRESSURE; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE VOMITING; PRACTICE GUIDELINE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; REVIEW; SLEEP APNEA SYNDROME; SMOKING CESSATION; STOMACH BYPASS; SUBSTANCE ABUSE; SURGEON; SURGICAL PATIENT; SURGICAL TECHNIQUE; SURGICAL TRAINING; THIAMINE DEFICIENCY; VENOUS THROMBOEMBOLISM; VERTICAL BANDED GASTROPLASTY; VITAMIN D DEFICIENCY; VITAMIN DEFICIENCY; WALKING; WERNICKE KORSAKOFF SYNDROME; WOUND HEALING; WOUND INFECTION; ZINC DEFICIENCY;

EID: 34249784828     PISSN: 10796533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Centers for Disease Control and Prevention. National Center for Health Statistics. Available at www.cdc.gov/nchs. Accessed 27 Apr 2007.
2. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-55.
3. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-7.
4. American Obesity Association. Available at www.obesity.org. Accessed 27 Apr 2007.
5. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.
6. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.
7. Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk. Arch Intern Med 2002;162:1867-72.
8. Poulain M, Doucet M, Major GC, et al. The effect of obesity on chronic respiratory disease: pathophysiology and therapeutic strategies. CMAJ 2006;174:1293-9.
9. Valencia-Flores M, Orea A, Castano VA, et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obes Res 2000;8:262-9.
10. Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133:635-46.
11. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85.
12. Garfinkel L. Overweight and cancer. Ann Intern Med 1985;103(6 Pt 2):1034-6.
13. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004;89:2583-9.
14. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142:532-46.
15. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. Swedish Obese Subjects Study Scientific Group. N Engl J Med 2004;351:2683-93.
16. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232:515-29.
17. Nguyen NT, Root J, Zainabadi K, et al. Accelerated growth of bariatric surgery with the introduction of minimally invasive surgery. Arch Surg 2005;140:1198-203.
18. Saltzman E, Anderson W, Apovian CM, et al. Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res 2005;13:234-43.
19. Buchwald H. A bariatric surgery algorithm. Obes Surg 2002;12:733-50.
20. Sarker S, Myers J, Serot J, Shayani V. Three-year follow-up weight loss results for patients undergoing laparoscopic adjustable gastric banding at a major university medical center: does the weight loss persist? Am J Surg 2006;191:372-6.
21. Galvani C, Gorodner M, Moser F, et al. Laparoscopic adjustable gastric band versus laparoscopic Roux-en-Y gastric bypass: ends justify the means? Surg Endosc 2006;20:934-41.
22. Kendrick ML, Dakin GF. Surgical approaches to obesity. Mayo Clin Proc 2006;81(10 Suppl):S18-S24.
23. Chapman AE, Kiroff G, Game P, et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 2004;135:326-51.
24. Lambert DM, Sudan R, Forse A. Choice of bariatric procedures. In: Farraye FA, Forse RA, editors. Bariatric surgery: a primer for your medical practice. Thorofare (NJ): SLACK Inc; 2006:45-64.
25. Fisher BL. Comparison of recovery time after open and laparoscopic gastric bypass and laparoscopic adjustable banding. Obes Surg 2004;14:67-72.
26. Parikh MS, Fielding GA, Ren CJ. U.S. experience with 749 laparoscopic adjustable gastric bands: intermediate outcomes. Surg Endosc 2005;19:1631-5.
27. De Waele B, Lauwers M, Van Nieuwenhove Y, Delvaux G. Outpatient laparoscopic gastric banding: initial experience. Obes Surg 2004;14:1108-10.
28. Dukhno O, Ovnat A, Levy I. Our experience with 250 laparoscopic adjustable silicone gastric bandings. Surg Endosc 2003;17:601-2.
29. Ahroni JH, Montgomery KF, Watkins BM. Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg 2005;15:641-7.
30. Ganesh R, Leese T, Rao AD, Baladas HG. Laparoscopic adjustable gastric banding for severe obesity. Singapore Med J 2006;47:661-9.
31. Lee WJ, Wang W, Wei PL, Huang MT. Weight loss and improvement of obesity-related illness following laparoscopic adjustable gastric banding procedure for morbidly obese patients in Taiwan. J Formos Med Assoc 2006;105:887-94.
32. Balsiger BM, Murr MM, Mai J, Sarr MG. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass. J Gastrointest Surg 2000;4:276-81.
33. van Gemert WG, van Wersch MM, Greve JW, Soeters PB. Revisional surgery after failed vertical banded gastroplasty: restoration of vertical banded gastroplasty or conversion to gastric bypass. Obes Surg 1998;8:21-8.
34. Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234:279-91.
35. Dresel A, Kuhn JA, McCarty TM. Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients. Am J Surg 2004;187:230-2.
36. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 2004;199:543-51.
37. Marceau P, Hould FS, Simard S, et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998;22:947-54.
38. Anthone GJ, Lord RV, DeMeester TR, Crookes PF. The duodenal switch operation for the treatement of morbid obesity. Ann Surg 2003;238:618-28.
39. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis [published erratum appears in JAMA 2005;293:1728]. JAMA 2004;292:1724-37.
40. NIH Consensus Development Program. Gastrointestinal surgery for severe obesity. NIH Consensus Statement Online 1991 Mar 25-27;9:1-20. Available at http://consensus.nih.gov/1991/1991GISurgeryObesity084html.htm. Accessed 27 Apr 2007.
41. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults - The Evidence Report. National Institutes of Health [published erratum appears in Obes Res 1998;6:464]. Obes Res 1998;6 Suppl 2:51S-209S.
42. Harper J, Madan AK, Ternovits CA, Tichansky DS. What happens to patients who do not follow-up after bariatric surgery? Am Surg 2007;73:181-4.
43. Shen R, Dugay G, Rajaram K, et al. Impact of patient follow-up on weight loss after bariatric surgery. Obes Surg 2004;14:514-9.
44. Shah M, Simha V, Garg A. Review: long-term impact of bariatric surgery on body weight, comorbidities, and nutritional status. J Clin Endocrinol Metab 2006;91:4223-31.
45. Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). European Association for Endoscopic Surgery. Surg Endosc 2005;19:200-21.
46. Istfan N, Anderson WA. Preoperative evaluation of the patient undergoing bariatric surgery. In: Farraye FA, Forse RA, editors. Bariatric surgery: a primer for your medical practice. Thorofare (NJ): SLACK Inc; 2006:67-81.
47. Brolin RE. Gastric bypass. Surg Clin North Am 2001;81:1077-95.
48. Lehman Center Weight Loss Surgery Expert Panel. Commonwealth of Massachusetts Betsy Lehman Center for Patient Safety and Medical Error Reduction Expert Panel on Weight Loss Surgery: executive report. Obes Res 2005;13:205-26.
49. Varela JE, Wilson SE, Nguyen NT. Outcomes of bariatric surgery in the elderty. Am Surg 2006;72:865-9.
50. Flum DR, Salem L, Elrod JA, et al. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 2005;294:1903-8.
51. Taylor CJ, Layani L. Laparoscopic adjustable gastric banding in patients > or = 60 years old: is it worthwhile? Obes Surg 2006;16:1579-83.
52. Murr MM, Siadati MR, Sarr MG. Results of bariatric surgery for morbid obesity in patients older than 50 years. Obes Surg 1995;5:399-402.
53. Courcoulas A, Schuchert M, Gatti G, Luketich J. The relationship of surgeon and hospital volume to outcome after gastric bypass surgery in Pennsylvania: a 3-year summary. Surgery 2003;134:613-23.
54. Sutur M, Giusti V, Heraief E, et al. Laparoscopic Roux-en-Y gastric bypass: initial 2-year experience. Surg Endosc 2003;17:603-9.
55. Andrew CG, Hanna W, Look D, et al. Early results after laparoscopic Roux-en-Y gastric bypass: effect of the learning curve. Can J Surg 2006;49:417-21.
56. DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg 2002;235:640-7.
57. Nguyen NT, Paya M, Stevens CM, et al. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg 2004;240:586-94.
58. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) [published erratum appears in Circulation 2006;113:e846]. Circulation 2002;105:1257-67.
59. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006;113:1361-76.
60. Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. American College of Physicians. Ann Intern Med 2006;144:581-95.
61. Vgontzas AN, Tan TL, Bixler EO, et al. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994;154:1705-11.
62. Deutzer J. Potential complications of obstructive sleep apnea in patients undergoing gastric bypass surgery. Crit Care Nurs Q 2005;28:293-9.
63. O'Rourke RW, Andrus J, Diggs BS, et al. Perioperative morbidity associated with bariatric surgery: an academic center experience. Arch Surg 2006;141:262-8.
64. Fernandez AZ Jr, Demaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg 2004;239:698-703.
65. Qaseem A, Snow V, Fitterman N, et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Ann Intern Med 2006;144:575-80.
66. Prystowsky JB, Morasch MD, Eskandari MK, et al. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients. Surgery 2005;138:759-65.
67. Keeling WB, Haines K, Stone PA, et al. Current indications for preoperative inferior vena cava filter insertion in patients undergoing surgery for morbid obesity. Obes Surg 2005;15:1009-12.
68. Atluri P, Raper SE. Factor V Leiden and postoperative deep vein thrombosis in patients undergoing open Roux-en-Y gastric bypass surgery. Obes Surg 2005;15:561-4.
69. Shiffman ML, Sugerman HJ, Kellum JM, et al. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 1991;86:1000-5.
70. Liem RK, Niloff PH. Prophylactic cholecystectomy with open gastric bypass operation. Obes Surg 2004;14:763-5.
71. Papasavas PK, Gagne DJ, Ceppa FA, Caushaj PF. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2006;2:41-7.
72. Caruana JA, McCabe MN, Smith AD, et al. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary? Surg Obes Relat Dis 2005;1:564-8.
73. Fobi M, Lee H, Igwe D, et al. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 2002;12:350-3.
74. Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995;169:91-7.
75. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. American Gastroenterological Association. Gastroenterology 2002;123:1705-25.
76. Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis 2001;21:71-80.
77. Mendler MH, Bouillet P, Le Sidaner A, et al. Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 1998;28:785-94.
78. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002;123:1367-84.
79. American Diabetes Association. 2007 Clinical practice recommendations. Available at www.diabetes.org/for-health-professionals-and-scientists/cpr.jsp. Accessed 30 Apr 2007.
80. Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006;141:375-80.
81. Coates PS, Fernstrom JD, Fernstrom, MH, et al. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004;89:1061-5.
82. Sarwer DB, Cohn NI, Gibbons LM, et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgical candidates. Obes Surg 2004;14:1148-56.
83. Alvarado R, Alami RS, Hsu G, et al. The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg 2005;15:1282-6.
84. Warner MA, Offord KP, Warner ME, et al. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989;64:609-16.
85. Wilson JA, Romagnuolo J, Byrne TK, et al. Predictors of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroenterol 2006;101:2194-9.
86. Levi D, Goodman ER, Patel M, Savransky Y. Critical care of the obese and bariatric surgical patient. Crit Care Clin 2003;19:11-32.
87. Livingston EH. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg 2004;188:105-10.
88. Podnos YD, Jimenez JC, Wilson SE, et al. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg 2003;138:957-61.
89. Nguyen NT, Lee SL, Goldman C, et al. Comparison of pulmonary function and postoperative pain after laparoscopic versus open gastric bypass: a randomized trial. J Am Coll Surg 2001;192:469-77.
90. Lawrence VA, Cornell JE, Smetana GW. Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians. American College of Physicians. Ann Intern Med 2006;144:596-608.
91. Wu EC, Barba CA. Current practices in the prophylaxis of venous thromboembolism in bariatric surgery. Obes Surg 2000;10:7-13.
92. Kalfarentzos F, Stavropoulou F, Yarmenitis S, et al. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg 2001;11:670-6.
93. Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002;12:19-24.
94. McGlinch BP, Que FG, Nelson JL, et al. Perioperative care of patients undergoing bariatric surgery. Mayo Clin Proc 2006;81(10 Suppl):S25-33.
95. Hess DT Jr, Forse RA. Immediate postoperative complications. In: Farraye FA, Forse RA, editors. Bariatric surgery: a primer for your medical practice. Thorofare (NJ): SLACK Inc; 2006:121-38.
96. Hamilton EC, Sims TL, Hamilton TT, et al. Clinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Endosc 2003;17:679-84.
97. Gonzalez R, Sarr MG, Smith CD, et al. Diagnosis and contemporary management of anastomotic leaks after gastric bypass for obesity. J Am Coll Surg 2007;204:47-55.
98. Anderson WA, Foresta L. Nutritional consequences following bariatric surgery. In: Farraye FA, Forse RA, editors. Bariatric surgery: a primer for your medical practice. Thorofare (NJ): SLACK Inc; 2006:141-55.
99. Elliot K. Nutritional considerations after bariatric surgery. Crit Care Nurs Q 2003;26:133-8.
100. McDonnell ME, Apovian CM, Hess DT Jr. Medical management of the patient after gastric-bypass surgery. In: Farraye FA, Forse RA, editors. Bariatric surgery: a primer for your medical practice. Thorofare (NJ): SLACK Inc; 2006:157-81.
101. Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric restrictive operations for morbid obestiy. J Gastrointest Surg 2000;4:464-9.
102. Shaffer EA. Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese. J Clin Gastroenterol 2006;40(3 Suppl 1):S44-50.
103. Garza E Jr, Kuhn J, Arnold D, et al. Internal hernias after laparoscopic Roux-en-Y gastric bypass. Am J Surg 2004;188:796-800.
104. Nelson WK, Houghton SG, Milliner DS, et al. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005;1:481-5.
105. Chang CG, Adams-Huet B, Provost DA. Acute post-gastric reduction surgery (APGARS) neuropathy. Obes Surg 2004;14:182-9.
106. Brolin RE, Gorman JH, Gorman RC, et al. Are vitamin B12 and folate deficiency clinically important after roux-en-Y gastric bypass? J Gastrointest Surg 1998;2:436-42.
107. McMahon MM, Sarr MG, Clark MM, et al. Clinical management after bariatric surgery: value of a multidisciplinary approach. Mayo Clin Proc
108. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3.
109. Holick MF. Vitamin D deficiency in obesity and health consequences. Curr Opin Endocrinol Diabetes 2006;13:412-8.
110. Brolin RE, Gorman JH, Gorman RC, et al. Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study. Arch Surg 1998;133:740-4.
111. Guyatt GH, Oxman AD, Ali M, et al. Laboratory diagnosis of iron-deficiency anemia: an overview [published erratum appears in J Gen Intern Med 1992;7:423]. J Gen Intern Med 1992;7:145-53.
112. Provenzale D, Reinhold RB, Golner B, et al. Evidence for diminished B12 absorption after gastric bypass: oral supplementation does not prevent low plasma B12 levels in bypass patients. J Am Coll Nutr 1992;11:29-35.
113. Rhode BM, Arseneau P, Cooper BA, et al. Vitamin B-12 deficiency after gastric surgery for obesity. Am J Clin Nutr 1996;63:103-9.
114. Sumner AE, Chin MM, Abrahm JL, et al. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery. Ann Intern Med 1996;124:469-76.
115. King JC, Shames DM, Woodhouse LR. Zinc homeostasis in humans. J Nutr 2000;130(5S Suppl):1360S-6S.